Pharsight

Phenylephrine Hydrochloride patents expiration

PHENYLEPHRINE HYDROCHLORIDE Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8859623 PARAGON BIOTECK Methods and compositions of stable phenylephrine formulations
Nov, 2033

(10 years from now)

Phenylephrine Hydrochloride is owned by Paragon Bioteck.

Phenylephrine Hydrochloride contains Phenylephrine Hydrochloride.

Phenylephrine Hydrochloride has a total of 1 drug patent out of which 0 drug patents have expired.

Phenylephrine Hydrochloride was authorised for market use on 21 March, 2013.

Phenylephrine Hydrochloride is available in solution/drops;ophthalmic dosage forms.

Phenylephrine Hydrochloride can be used as dilation of the pupil.

The generics of Phenylephrine Hydrochloride are possible to be released after 14 November, 2033.

Drugs and Companies using PHENYLEPHRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 21 March, 2013

Treatment: Dilation of the pupil

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage

PHENYLEPHRINE HYDROCHLORIDE family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic